Abstract
A novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2) has emerged in Wuhan, China since the end of December 2019 and has quickly spread all over the world in a matter of two months. To date, no specific treatment has been proven to be effective for coronavirus (COVID-19). With the rapid increase of infected patients and deaths, it is vital to explore an effective treatment for COVID-19. Current studies suggest that there exists cytokine storm in SARS-CoV-2-infected patients; some of the them will develop acute respiratory distress syndrome (ARDS) and multiple organ dysfunction, and even death. Mesenchymal stem cells (MSCs) possess the property of immunomodulation. Given the previous preclinical and clinical studies, MSCs therapy has shown safety and efficacy in the treatment of respiratory failure or ARDS. Based on similar principles, MSCs therapy may also be an effective therapy in the treatment of COVID-19. In this study, we summarized the clinical outcomes of MSCs for ARDS patients in some preclinical and clinical studies and discussed the application of MSCs for patients with COVID-19 in China and the related important issues with MSCs used during the outbreak.
Keywords: Mesenchymal stem cells, coronavirus disease 2019, acute respiratory distress syndrome, dysfunction, cytokine, syndrome.
Current Stem Cell Research & Therapy
Title:Mesenchymal Stem Cell-Based Therapy for COVID-19: Possibility and Potential
Volume: 16 Issue: 2
Author(s): Jing Xiong, Lei Bao, Hongbo Qi, Zhichun Feng*Yuan Shi*
Affiliation:
- Bayi Children’s Hospital, The Seventh Medical Center, PLA General Hospital, Beijing,China
- Department of Neonatology, Ministry of Education Key Laboratory of Child Development and Disorders; National Clinical Research Center for Child Health and Disorders; China International Science and Technology Cooperation base of Child development and Critical Disorders; Children’s Hospital of Chongqing Medical University; Chongqing Key Laboratory of Pediatrics, Chongqing, 400014,China
Keywords: Mesenchymal stem cells, coronavirus disease 2019, acute respiratory distress syndrome, dysfunction, cytokine, syndrome.
Abstract: A novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2) has emerged in Wuhan, China since the end of December 2019 and has quickly spread all over the world in a matter of two months. To date, no specific treatment has been proven to be effective for coronavirus (COVID-19). With the rapid increase of infected patients and deaths, it is vital to explore an effective treatment for COVID-19. Current studies suggest that there exists cytokine storm in SARS-CoV-2-infected patients; some of the them will develop acute respiratory distress syndrome (ARDS) and multiple organ dysfunction, and even death. Mesenchymal stem cells (MSCs) possess the property of immunomodulation. Given the previous preclinical and clinical studies, MSCs therapy has shown safety and efficacy in the treatment of respiratory failure or ARDS. Based on similar principles, MSCs therapy may also be an effective therapy in the treatment of COVID-19. In this study, we summarized the clinical outcomes of MSCs for ARDS patients in some preclinical and clinical studies and discussed the application of MSCs for patients with COVID-19 in China and the related important issues with MSCs used during the outbreak.
Export Options
About this article
Cite this article as:
Xiong Jing , Bao Lei , Qi Hongbo , Feng Zhichun *, Shi Yuan *, Mesenchymal Stem Cell-Based Therapy for COVID-19: Possibility and Potential, Current Stem Cell Research & Therapy 2021; 16 (2) . https://dx.doi.org/10.2174/1574888X15666200601152832
DOI https://dx.doi.org/10.2174/1574888X15666200601152832 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
One Course, Two … Four Courses – A Bioentrepreneurship Concentration – Case Studies: Johns Hopkins University and the University of San Francisco
Technology Transfer and Entrepreneurship (Discontinued) Editorial [ Hot Topic: Host Defense Peptide: Roles and Application (Guest Editor: Alessandro Tossi)]
Current Protein & Peptide Science Signal Transduction of Radiation and/or Hyperthermic Cancer Therapies
Current Signal Transduction Therapy How to Manage the Infectious Risk under Anti-TNF in Inflammatory Bowel Disease
Current Drug Targets Targeting SKCa Channels in Cancer: Potential New Therapeutic Approaches
Current Medicinal Chemistry Antibody Based Therapies in Acute Leukemia
Current Drug Targets Synthesis and Biological Evaluation of the Pyrazole Class of Cyclooxygenase- 2-Inhibitors
Letters in Organic Chemistry Treasures Hunt in Old Mines: Terminalia chebula-Based Traditional Herbal Medicinal Products
The Natural Products Journal Murine Models of Vpr-Mediated Pathogenesis
Current HIV Research Targeting the Multifaceted HuR Protein, Benefits and Caveats
Current Drug Targets Immunomodulatory Effects of Soybeans and Processed Soy Food Compounds
Recent Patents on Food, Nutrition & Agriculture Meet Our Editorial Board Member:
Current Tissue Engineering (Discontinued) Infrared-Spectroscopy: A Non-Invasive Tool for Medical Diagnostics and Drug Analysis
Current Medicinal Chemistry STAT-3 Inhibitors: State of the Art and New Horizons for Cancer Treatment
Current Medicinal Chemistry Brain Molecules and Appetite: The Case of Oleoylethanolamide
Central Nervous System Agents in Medicinal Chemistry Carbon Nanotubes in the Treatment of Skin Cancers: Safety and Toxic ological Aspects
Pharmaceutical Nanotechnology Probiotics and Different Efficacy, How it can be Managed?
Current Drug Therapy The Mediterranean Diet: A Combination of Beneficial Elements for Cardiovascular Disease
Current Nutrition & Food Science New Approaches for the Treatment of Pain: The GDNF Family of Neurotrophic Growth Factors
Current Topics in Medicinal Chemistry Efficacy and Safety of H1-Antihistamines: An Update
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry